Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601264-26-000004
Filing Date
2026-02-09
Accepted
2026-02-09 16:47:01
Documents
1
Period of Report
2026-02-05

Document Format Files

Seq Description Document Type Size
1 form4-02092026_090257.html 4  
1 form4-02092026_090257.xml 4 4274
  Complete submission text file 0001601264-26-000004.txt   5970
Mailing Address C/O SAMSARA BIOCAPITAL, LLC 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address
Dybbs Michael (Reporting) CIK: 0001601264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-43105 | Film No.: 26612152

Mailing Address 27081 ALISO CREEK ROAD SUITE 125 ALISO VIEJO CA 92656
Business Address 27081 ALISO CREEK ROAD SUITE 125 ALISO VIEJO CA 92656 949-284-6904
SpyGlass Pharma, Inc. (Issuer) CIK: 0001778922 (see all company filings)

EIN.: 833044245 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)